News

Filter

Tag: CAR-T

May 30, 2025
Innovative immunotherapy shows promise against aggressive T cell cancers
WashU startup’s “off-the-shelf” CAR-T cell therapy evaluated in international clinical trial.
News Release
December 16, 2024
$10.8 million grant supports cutting-edge leukemia research
NIH renews prestigious program for blood cancer research at WashU Medicine.
News Release
November 22, 2024
World leaders in ending blood cancer
The Siteman Blood Cancer Center, which brings together the multidisciplinary expertise of WashU Medicine physicians, has long been at the forefront of transforming care. .
Outlook Magazine
July 22, 2020
2 immunotherapies merged into single, more effective treatment
Mouse study suggests strategy may work against variety of cancers.
News Release
August 26, 2019
Seed funding
Research investment targets lesser-known form of cancer.
Outlook Magazine
March 7, 2019
The warrior within
Immune-based therapies are becoming a reality for cancer care.
Outlook Magazine
October 2, 2018
DeSelm honored by NIH for innovative cancer research
Radiation oncologist selected for High-Risk, High-Reward Research Program.
News Release
March 5, 2018
CRISPR enhances cancer immunotherapy
Gene editing expands reach of therapeutic T cells, in mice.
News Release
November 6, 2017
$6 million supports leukemia research
DiPersio receives NCI outstanding investigator award.
News Release
October 18, 2017
New gene-altering treatment offered for certain blood cancers
CAR-T immunotherapy may help patients who don’t respond to standard treatments.
News Release, Video